Structural and functional characteristics of muscle from diabetic rodent small intestine

Thomas Nowak, B. Harrington, J. P. Weisbruch, J. H. Kalbfleisch

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

After 30 days of streptozotocin-induced diabetes, the small intestine from untreated diabetic, insulin-treated diabetic, and nondiabetic rodents was excised in toto and measured. Despite a net loss in body weight, the diabetic animals showed a near twofold increase in small intestinal weight. This was characterized by a 148% increase in mucosal mass as well as a 39% increase in intestinal smooth muscle mass (P <0.05, respectively). The diabetic intestine was significantly longer and had a greater diameter and surface area. Diabetes significantly increased mucosal mass per unit surface area but produced an insignificant decrease in smooth muscle mass per unit surface area. Insulin treatment of the diabetic animals prevented the increase in total mucosal mass and mucosal mass per unit surface area. Insulin treatment also prevented the increase in smooth muscle mass, but reduced smooth muscle mass per unit surface area to a level significantly less than that found in nondiabetic intestine. In vitro dose-response studies of circular and longitudinal small intestinal muscle from the diabetic animals showed normal tension development and sensitivity to both bethanechol chloride and physostigmine. These observations show that the diabetic state produces alterations in not only mucosal but also smooth muscle mass in the small intestine. However, despite these morphological changes, diabetic intestinal smooth muscle retains its sensitivity to cholinergic stimulation and its capacity for tension generation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume258
Issue number5 21-5
StatePublished - 1990
Externally publishedYes

Fingerprint

Small Intestine
Smooth Muscle
Rodentia
Muscles
Insulin
Intestines
Bethanechol
Physostigmine
Experimental Diabetes Mellitus
Cholinergic Agents
Longitudinal Studies
Body Weight
Weights and Measures

Keywords

  • diabetes mellitus
  • intestinal smooth muscle
  • smooth muscle growth

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Structural and functional characteristics of muscle from diabetic rodent small intestine. / Nowak, Thomas; Harrington, B.; Weisbruch, J. P.; Kalbfleisch, J. H.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 258, No. 5 21-5, 1990.

Research output: Contribution to journalArticle

@article{0258327fffa94590b39d149824cddb2c,
title = "Structural and functional characteristics of muscle from diabetic rodent small intestine",
abstract = "After 30 days of streptozotocin-induced diabetes, the small intestine from untreated diabetic, insulin-treated diabetic, and nondiabetic rodents was excised in toto and measured. Despite a net loss in body weight, the diabetic animals showed a near twofold increase in small intestinal weight. This was characterized by a 148{\%} increase in mucosal mass as well as a 39{\%} increase in intestinal smooth muscle mass (P <0.05, respectively). The diabetic intestine was significantly longer and had a greater diameter and surface area. Diabetes significantly increased mucosal mass per unit surface area but produced an insignificant decrease in smooth muscle mass per unit surface area. Insulin treatment of the diabetic animals prevented the increase in total mucosal mass and mucosal mass per unit surface area. Insulin treatment also prevented the increase in smooth muscle mass, but reduced smooth muscle mass per unit surface area to a level significantly less than that found in nondiabetic intestine. In vitro dose-response studies of circular and longitudinal small intestinal muscle from the diabetic animals showed normal tension development and sensitivity to both bethanechol chloride and physostigmine. These observations show that the diabetic state produces alterations in not only mucosal but also smooth muscle mass in the small intestine. However, despite these morphological changes, diabetic intestinal smooth muscle retains its sensitivity to cholinergic stimulation and its capacity for tension generation.",
keywords = "diabetes mellitus, intestinal smooth muscle, smooth muscle growth",
author = "Thomas Nowak and B. Harrington and Weisbruch, {J. P.} and Kalbfleisch, {J. H.}",
year = "1990",
language = "English (US)",
volume = "258",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "5 21-5",

}

TY - JOUR

T1 - Structural and functional characteristics of muscle from diabetic rodent small intestine

AU - Nowak, Thomas

AU - Harrington, B.

AU - Weisbruch, J. P.

AU - Kalbfleisch, J. H.

PY - 1990

Y1 - 1990

N2 - After 30 days of streptozotocin-induced diabetes, the small intestine from untreated diabetic, insulin-treated diabetic, and nondiabetic rodents was excised in toto and measured. Despite a net loss in body weight, the diabetic animals showed a near twofold increase in small intestinal weight. This was characterized by a 148% increase in mucosal mass as well as a 39% increase in intestinal smooth muscle mass (P <0.05, respectively). The diabetic intestine was significantly longer and had a greater diameter and surface area. Diabetes significantly increased mucosal mass per unit surface area but produced an insignificant decrease in smooth muscle mass per unit surface area. Insulin treatment of the diabetic animals prevented the increase in total mucosal mass and mucosal mass per unit surface area. Insulin treatment also prevented the increase in smooth muscle mass, but reduced smooth muscle mass per unit surface area to a level significantly less than that found in nondiabetic intestine. In vitro dose-response studies of circular and longitudinal small intestinal muscle from the diabetic animals showed normal tension development and sensitivity to both bethanechol chloride and physostigmine. These observations show that the diabetic state produces alterations in not only mucosal but also smooth muscle mass in the small intestine. However, despite these morphological changes, diabetic intestinal smooth muscle retains its sensitivity to cholinergic stimulation and its capacity for tension generation.

AB - After 30 days of streptozotocin-induced diabetes, the small intestine from untreated diabetic, insulin-treated diabetic, and nondiabetic rodents was excised in toto and measured. Despite a net loss in body weight, the diabetic animals showed a near twofold increase in small intestinal weight. This was characterized by a 148% increase in mucosal mass as well as a 39% increase in intestinal smooth muscle mass (P <0.05, respectively). The diabetic intestine was significantly longer and had a greater diameter and surface area. Diabetes significantly increased mucosal mass per unit surface area but produced an insignificant decrease in smooth muscle mass per unit surface area. Insulin treatment of the diabetic animals prevented the increase in total mucosal mass and mucosal mass per unit surface area. Insulin treatment also prevented the increase in smooth muscle mass, but reduced smooth muscle mass per unit surface area to a level significantly less than that found in nondiabetic intestine. In vitro dose-response studies of circular and longitudinal small intestinal muscle from the diabetic animals showed normal tension development and sensitivity to both bethanechol chloride and physostigmine. These observations show that the diabetic state produces alterations in not only mucosal but also smooth muscle mass in the small intestine. However, despite these morphological changes, diabetic intestinal smooth muscle retains its sensitivity to cholinergic stimulation and its capacity for tension generation.

KW - diabetes mellitus

KW - intestinal smooth muscle

KW - smooth muscle growth

UR - http://www.scopus.com/inward/record.url?scp=0025295015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025295015&partnerID=8YFLogxK

M3 - Article

C2 - 2185667

AN - SCOPUS:0025295015

VL - 258

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 5 21-5

ER -